These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27382672)

  • 21. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of cyclooxygenase-2 and p53 and their correlation in carcinoma of larynx].
    Lu H; Gong S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):421-3. PubMed ID: 15499987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of EGFR and PCNA, and DNA content in squamous cell carcinoma of larynx].
    Ling L; Zhou MY; Wang HE
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Mar; 14(3):99-101. PubMed ID: 12541404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expressions of PCNA, p53, p21(WAF-1) and cell proliferation in fetal esophageal epithelia: comparative study with adult esophageal lesions from subjects at high-incidence area for esophageal cancer in Henan, North China.
    Xing Y; Ning Y; Ru LQ; Wang LD
    World J Gastroenterol; 2003 Jul; 9(7):1601-3. PubMed ID: 12854173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
    Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinical significance of molecular findings in surgically resected margins of the primary tumor laryngeal carcinoma].
    Jin X; Qian M; Xu Y; Zheng L; Wang J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Dec; 20(24):1111-3. PubMed ID: 17357515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
    Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
    Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
    Broich G; Lavezzi AM; Biondo B; Pignataro LD
    In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin's disease at presentation and relapse.
    Naresh KN; O'Conor GT; Soman CS; Johnson J; Advani SH; Magrath IT; Bhatia KG
    Hum Pathol; 1997 May; 28(5):549-55. PubMed ID: 9158703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
    Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
    Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent.
    Osman I; Sherman E; Singh B; Venkatraman E; Zelefsky M; Bosl G; Scher H; Shah J; Shaha A; Kraus D; Cordon-Cardo C; Pfister DG
    J Clin Oncol; 2002 Jul; 20(13):2980-7. PubMed ID: 12089228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma.
    Qin LF; Ng IO; Fan ST; Ng M
    Int J Cancer; 1998 Aug; 79(4):424-8. PubMed ID: 9699537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
    Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
    Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of usefulness of PCNA and oncoprotein p53 staining in prediction of the recurrences in subjects operated on for laryngeal carcinoma].
    Morawski K; Namysłowski G; Gabriel A; Pietrawska V; Ziółkowski A; Urbaniec P
    Otolaryngol Pol; 2000; 54(4):393-9. PubMed ID: 11070693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.